NIPT (Harmony (TM) Prenatal Test) is a non-invasive blood test to determine the risk of common fetal genetic conditions – Trisomy 21 (Down’s Syndrome), Trisomy 18 and Trisomy 13.
NIPT uses a novel and complex laboratory test that analyzes cell-free DNA (cfDNA) in maternal blood. The sample is analyzed by our partner laboratory: Ariosa Diagnostics, Inc.
This test can be offered to low-risk and high-risk pregnant women with singleton and twin pregnancies of at least 10 weeks gestational age.
NIPT assesses the risks of these more common genetic conditions, but it does not rule out all fetal anomalies. In addition, NIPT is considered a screening test – any positive results must be assessed further by invasive prenatal genetic diagnostic testing (chorionic villus sampling or amniocentesis).